Perifosine

From WikiMD.org
Jump to navigation Jump to search

Perifosine

Perifosine (pronunciation: per-i-fo-sine) is a type of alkylphospholipid that is primarily used in the field of oncology for its potential anti-cancer properties.

Etymology

The term "Perifosine" is derived from the chemical compound class it belongs to, known as phospholipids. The prefix "peri-" is of Greek origin, meaning "around" or "surrounding", which may refer to the compound's ability to interact with the lipid bilayer of cells.

Usage

Perifosine is an experimental drug that has been studied for its potential use in the treatment of various types of cancer. It works by inhibiting the Akt pathway, a signal transduction pathway that promotes cell growth and survival. By blocking this pathway, perifosine may be able to slow down or stop the growth of cancer cells.

Related Terms

  • Alkylphospholipid: A class of synthetic compounds that mimic naturally occurring phospholipids, but with altered properties that can make them useful in cancer treatment.
  • Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
  • Akt pathway: A signal transduction pathway that promotes cell growth and survival, making it a target for cancer treatment.
  • Signal transduction: The process by which a chemical or physical signal is transmitted through a cell as a series of molecular events.

See Also

  • KRX-0401: The code name for perifosine during its experimental stages.
  • Cancer treatment: The use of surgery, radiation, medications and other therapies to cure cancer, shrink cancer or stop the symptoms of cancer.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski